Doroin, Michelle .

HRN: 00-71-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2025
CEFAZOLIN 1GM (VIAL)
03/25/2025
03/25/2025
IV
2g
PTOR
Mutiple Myoma Uteri; GO
Waiting Final Action 
03/25/2025
CEFUROXIME 1.5GM (VIAL)
03/25/2025
03/26/2025
IV
1.5 G
Q8
SP TAHBSO
Waiting Final Action 
03/25/2025
CEFUROXIME 500MG (TAB)
03/26/2025
04/02/2025
PO
1 Tab
BID
SP TAHBSO
Waiting Final Action 
03/25/2025
MUPIROCIN 2%, 15G (TUBE)
03/25/2025
04/01/2025
TOPICAL
Apply On Surgical Site
BID
SP TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: